|What Caught Our Eye (WCOE), March 10, 2017
What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention.
Affordable Care Act
Replacement Bill Introduced In Congress
The American Health Care Act (AHCA) was introduced in the House earlier this week. A great deal has been written analyzing this legislation, and so we only highlight a few articles here looking at different aspects.
— Health Affairs (@Health_Affairs) March 7, 2017
A breakdown of the premium cost changes:
Republican health care plan hits older and poorer enrollees the hardest https://t.co/tgEOIbWODm
— Vox (@voxdotcom) March 7, 2017
CBPP Analysis of the Bill
The Center on Budget and Policy Priorities has a lot of excellent analysis on the AHCA. This article highlights the fact that “in 11 states, tax credits would be cut more than in half” to help people pay their premiums. It also states: “Consumers’ costs would probably increase even more than tax credits would fall, since the House plan would likely cause individual market premiums to rise.”
— Center on Budget (@CenterOnBudget) March 9, 2017
ACA Support Continues to Climb
While repeal and replacement of the ACA is being debated, the law is seeing some of its highest support on record.
— Kaiser Family Found (@KaiserFamFound) February 24, 2017
The Reality of Cancer Care
STAT News has an honest and sobering article about the need to “do better in communicating the reality of cancer care to patients.”
— STAT (@statnews) March 9, 2017
Palliative care is still misunderstood, often incorrectly equated to end-of-life care or hospice. Palliative and end-of-life care must be seen as two different types of care, each offering distinct benefits for cancer patients when appropriate. “How and when people are referred to palliative care should be prioritised according to cancer patients, a new study in the Oncology Nursing Forum has found.”
Researchers survey cancer patients, nurses to identify priorities for future research into palliative care https://t.co/pNqVh0BH15
— Carenet Healthcare (@CarenetHealth) March 9, 2017
Coping With Cancer
Some Patients Discontinuing Highly-Effective CML Drug
A drug used to treat Chronic Myelogenous Leukemia (CML) has been so effective that some doctors now discuss discontinuing treatment with certain patients.
— STAT (@statnews) March 3, 2017
More From “What Caught Our Eye” »
Follow us on Twitter: @canceradvocacy